Ghezzo et al. retrospectively studied 43 patients suffering from prostate carcinoma in whom baseline 68Ga-PSMA-11 PET/CT was performed and that had diagnostic biopsy (biopsy ISUP grades) and full radical prostatectomy (post-surgical ISUP grade) performed as the sole therapy [23]. This evidence concerns the gene FOLH1 and prostate carcinoma.